BSE filing, NSE: SOMDUTTFIN. Summary written from the filing by ALFA Finder's alert engine.
Crescentis Capital Ltd: key numbers
- Share price
- ₹107.05
- Market cap
- ₹182.1 Cr
- Revenue (annual)
- ₹1.48 Cr
- Net profit (annual)
- ₹-2.53 Cr
- P/E (TTM)
- 154.6×Sector 19.8×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Crescentis Capital Ltd
All →Crescentis Capital Capital Structure Change
Crescentis Capital approved Rights Issue terms: 1,02,08,129 shares at ₹78, raising ₹79.62 Crore. Record date November 4; issue closes November 27, 2026.
- Value
- ₹79.62 Cr
Crescentis Capital Board Meeting Date
Crescentis Capital will hold a Fund-Raising Committee meeting on 29 October 2026 to approve the terms of a proposed rights issue of up to Rs 80 crore. The filing is a prior intimation of that committee meeting.
Crescentis Capital Other Announcement
Crescentis Capital Limited submitted the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as per SEBI regulations.
Crescentis Capital Other Announcement
Crescentis Capital Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Crescentis Capital Employee Stock Options
Crescentis Capital Limited granted 5,00,000 stock options to its Managing Director, Mr. Subba Rao Veeravenkata Meka, under the company's 2025 ESOS scheme.
Crescentis Capital Fund Raise of ₹80 Cr
Crescentis Capital Limited's board has approved a rights issue of equity shares for up to Rs 80 Crore. The board also approved the Draft Letter of Offer.
- Value
- ₹80.00 Cr
Other adverse business impact announcements
All →Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals temporarily shuts down its Kochi Hydrogen plant from 29 October 2026 for pipeline repair and urgent maintenance. Reopening date to be communicated separately.
IIFL Capital Services Adverse Business Impact
IIFL Capital Services' subsidiary surrendered its SEBI Investment Adviser registration, effective October 28, 2026. The company states there is no material monetary impact and no penalty.